
Results
131
The top dividend paying companies in the stock market today.
131 companies
Hualan Biological Engineering
Market Cap: CN¥30.8b
Researches, develops, produces, and commercializes blood products, vaccines, and genetic engineering products in China and internationally.
002007
CN¥16.83
7D
2.2%
1Y
-0.6%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide.
4151
JP¥2,492.00
7D
2.9%
1Y
-3.0%
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.3b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳296.40
7D
3.7%
1Y
1.6%
Apeloa PharmaceuticalLtd
Market Cap: CN¥18.1b
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥15.73
7D
3.3%
1Y
-3.6%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.47
7D
1.1%
1Y
70.0%
CSL
Market Cap: AU$87.9b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$181.81
7D
1.6%
1Y
-34.4%
Vistin Pharma
Market Cap: NOK 909.1m
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 20.50
7D
1.0%
1Y
-14.6%
Yunnan Baiyao GroupLtd
Market Cap: CN¥101.1b
Engages in the pharmaceutical business in China.
000538
CN¥56.66
7D
1.1%
1Y
-3.9%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$30.00
7D
-1.3%
1Y
18.4%
Yabao Pharmaceutical Group
Market Cap: CN¥4.9b
Researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally.
600351
CN¥7.04
7D
2.9%
1Y
14.5%
Tonghua Dongbao Pharmaceutical
Market Cap: CN¥17.9b
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
600867
CN¥9.21
7D
0.8%
1Y
7.1%
KYORIN Pharmaceutical
Market Cap: JP¥81.1b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,411.00
7D
0.4%
1Y
-4.2%
Daewon Pharmaceutical
Market Cap: ₩288.3b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩13,450.00
7D
3.9%
1Y
-5.1%
CSPC Pharmaceutical Group
Market Cap: HK$90.8b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$7.94
7D
7.6%
1Y
54.8%
YungShin Global Holding
Market Cap: NT$14.8b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$55.40
7D
-1.6%
1Y
3.6%
Highnoon Laboratories
Market Cap: PK₨59.2b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,117.27
7D
1.0%
1Y
26.2%
Hoechst Pakistan
Market Cap: PK₨40.4b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,191.66
7D
2.6%
1Y
60.7%
Sam-A Pharm
Market Cap: ₩102.0b
Operates as a pharmaceutical company in South Korea.
A009300
₩16,710.00
7D
0.5%
1Y
-10.5%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥32.5b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥49.50
7D
0.8%
1Y
46.2%
TTY Biopharm
Market Cap: NT$19.6b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$78.90
7D
-0.5%
1Y
8.4%
BioGaia
Market Cap: SEK 10.5b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 104.10
7D
5.7%
1Y
-0.3%
Sichuan Kelun Pharmaceutical
Market Cap: CN¥55.1b
Researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China.
002422
CN¥34.61
7D
6.9%
1Y
11.1%
Shijiazhuang Yiling Pharmaceutical
Market Cap: CN¥35.2b
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
CN¥21.05
7D
12.4%
1Y
20.6%
Dong-E-E-JiaoLtd
Market Cap: CN¥31.6b
Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.
000423
CN¥49.17
7D
1.8%
1Y
-15.8%
Wuhan Keqian BiologyLtd
Market Cap: CN¥7.7b
Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.
688526
CN¥16.58
7D
3.2%
1Y
14.1%
TSH Biopharm
Market Cap: NT$2.1b
Develops and markets pharmaceutical products in Taiwan and Asia.
8432
NT$54.80
7D
0.7%
1Y
-14.2%
Guilin Sanjin Pharmaceutical
Market Cap: CN¥9.2b
Engages in the research, production, and sale of traditional Chinese and natural medicines in China.
002275
CN¥15.61
7D
1.8%
1Y
5.2%
Tempo Scan Pacific
Market Cap: Rp13.2t
Engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally.
TSPC
Rp2,920.00
7D
-2.7%
1Y
12.3%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$28.00
7D
1.4%
1Y
-3.4%
China Shineway Pharmaceutical Group
Market Cap: HK$6.9b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$9.15
7D
4.5%
1Y
8.8%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.9b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$30.90
7D
-3.4%
1Y
6.6%
ASKA Pharmaceutical HoldingsLtd
Market Cap: JP¥58.0b
Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.
4886
JP¥2,044.00
7D
0.1%
1Y
-1.8%
Daito PharmaceuticalLtd
Market Cap: JP¥37.5b
Engages in the manufacture and sale of pharmaceutical products worldwide.
4577
JP¥1,262.00
7D
2.7%
1Y
19.6%
Astena Holdings
Market Cap: JP¥19.4b
Manufactures and sells medicine-related products in Japan.
8095
JP¥480.00
7D
2.6%
1Y
-4.2%
Bioventix
Market Cap: UK£111.0m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£21.25
7D
0%
1Y
-44.4%
Merck
Market Cap: Rp1.4t
Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.
MERK
Rp3,090.00
7D
-0.3%
1Y
-11.7%